[The evaluation of the efficacy of treatment in glaucoma associated with Sturge-Weber syndrome].
OBJECTIVE
To estimate the efficiency of glaucoma treatment in Sturge-Weber syndrome.


METHODS
4 patients with Sturge-Weber syndrome and the consecutive glaucoma seen at the Department of Ophthalmology in Bialystok between the years 1999-20005, were reviewed. Glaucoma associated with Sturge-Weber syndrome was diagnosed at the age of 6 months in 1 patient, of 10-11 years in 2 patients and of 14 years in 1 patients. All patients underwent surgery. 2 eyes underwent trabeculectomy and 2 eyes had nonpenetrating deep sclerectomy with SKGel implant.


RESULTS
Before the surgery the intraocular pressure was 35.2 mmHg (range from 25 to 48 mmHg). All patients required anti-glaucoma medications after surgery to keep intraocular pressure less than 22 mmHg. After surgery the mean intraocular pressure was 26.25 mmHg (range from 22 to 32 mmHg). 2 patients required 2 medications: Betoptic, and/or Trusopt, and/or Xalatan and 2 patients required 1 medication. After antiglaucoma medications mean IOP was 15.2 mmHg (range from 12 to 18 mmHg).


CONCLUSIONS
The results of therapy for glaucoma associated with the Sturge-Weber syndrome are often disappointing.
Oziebło-Kupczyk
Monika
M
Kliniki Okulistyki Dzieciecej Akademii Medycznej w Białymstoku.
Urban
Beata
B
Mrugacz
Małgorzata
M
Bakunowicz-Lazarczyk
Alina
A
D000293:Adolescent; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D002257:Carbonic Anhydrase Inhibitors / Q000627:therapeutic use; D002648:Child; D005260:Female; D005901:Glaucoma / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology / Q000601:surgery*; D006801:Humans; D007223:Infant; D007429:Intraocular Pressure; D013341:Sturge-Weber Syndrome / Q000150:complications*; D014130:Trabeculectomy; D016896:Treatment Outcome
D000319:Adrenergic beta-Antagonists; D002257:Carbonic Anhydrase Inhibitors